跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRZ-ROSUVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRZ-ROSUVASTATIN
Authorized
STANDARD
PRZ-ROSUVASTATIN
pharmaris canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1bf6e5a9374cd229
Company
pharmaris canada inc
Type
Standard
Approval Details
Approval Id
1bf6e5a9374cd229
Drug Approval Canada Name
PRZ-ROSUVASTATIN
Product Name
PRZ-ROSUVASTATIN
Status
Marketed
Status Date
2021-10-12
Original Market Date
2021-10-12
Din
02505576
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA07 ROSUVASTATIN
Atc Name
c 10 aa 07
Aig Number
0148963004
Company Name
pharmaris canada inc
Company Address
102, 8310 130th Street, Surrey, British Columbia, Canada, V3W 8J9
Active Ingredients
ROSUVASTATIN (ROSUVASTATIN CALCIUM)
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1bf6e5a9374cd229
Type
Standard
Back to Health Canada Approvals